EOS Med Chem, Medicinal Chemical is Big

2017年11月17日星期五

Eos Med Chem, Product List--Small molecule inhibitors of Clinical---40027

Small molecule inhibitors of Clinical.

Abametapir;Ha-44; BRN-0123183 CAS：1762-34-1，, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗头虱的基质金属蛋白酶-抑制剂。

Abemaciclib Mesylate;LY-2835219

CAS：1231929-97-7(Abemaciclib)；1231930-82-7(Abemaciclib Mesylate), HPLC 99%, NMR, LCMS is ok, stock more than 10g.一种潜在的治疗乳腺癌和非小细胞肺癌的周期性依赖性激酶（CDK4/6）抑制剂。

Acelarin;CPF-31; NUC-1031，CAS：840506-29-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗胰腺癌的嘧啶合成拮抗剂。

Acalabrutinib;ACP-196， CAS：1420477-60-6, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗慢性淋巴细胞白血病的布鲁顿酪氨酸激酶抑制剂。

ALKS-8700; CAS：1577222-14-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗多发性硬化症的G蛋白偶联受体109A活化剂。

Alpelisib;BYL-719; NVP-BYL-719; NVPBYL-719， CAS：1217486-61-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗头颈部鳞状细胞癌,乳腺癌,非小细胞肺癌和实体肿瘤的磷脂酰肌醇-3-羟激酶抑制剂。

Amenamevir;M-5220; ASP-2151， CAS：841301-32-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗疱疹病毒感染的解螺旋酶-引物酶抑制剂。

Amitifadine Hydrochloride;DOV-21947; EB-1010

CAS：410074-73-6(Amitifadine)， 410074-74-7(Amitifadine Hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗重度抑郁症的多巴胺，去甲肾上腺素和5-羟色胺再摄取抑制剂。

Anacetrapib;MK-0859， CAS：875446-37-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗动脉粥样硬化和高胆固醇血症的胆固醇酯转移蛋白（CETP）抑制剂。

Andolast;CR-2039， CAS：132640-22-3, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗哮喘、过敏性鼻炎和慢性阻塞性肺疾病的钙激活钾通道开放剂。

Anlotinib Dihydrochloride (盐酸安罗替尼);AL-3818

CAS：1058156-90-3(Anlotinib)， 1360460-82-7(Anlotinib Dihydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗转移性结直肠癌和晚期胃腺癌的多靶点激酶抑制剂。

Apalutamide;JNJ-56021927; ARN-509; JNJ-927, CAS:956104-40-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗非转移性去势抵抗前列腺癌的雄激素受体拮抗剂.

Apaziquone;NSC-382459; EO-9; E-85; 050; 053; NOR-701

CAS号114560-48-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗膀胱癌的DNA烷化剂。

Arimoclomol Maleate;BRX-220， CAS：289893-25-0(Arimoclomol)，289893-26-1(Arimoclomol maleate), HPLC 99%, NMR, LCMS is ok, stock more than 10g.一种潜在的治疗C型尼曼 - 匹克病（NP-C）和肌萎缩性脊髓侧索硬化症（ALS）的药物。

Arzoxifene Hydrochloride;LY-353381; SERM-3

CAS：182133-25-1(Arzoxifene)，182133-27-3(Arzoxifene Hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗绝经后妇女的乳腺癌和骨质疏松症的选择性雌激素受体调节剂（SERM）。

Asapiprant;S-555739, CAS：932372-01-5, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗过敏性鼻炎的前列腺素D受体拮抗剂。

Aspartyl-alanyl-diketopiperazine;DMI-9523; DA-DKP; DADKP

CAS：397847-46-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗骨关节炎的核转录因子NF-κB激活抑制剂。

Avatrombopag Maleate;E-5501; AKR-501; AS-1670542; YM-477

CAS：570406-98-3(Avatrombopag)，677007-74-8(Avatrombopag Maleate), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗特发血小板减少性紫癜和慢性肝病引起的血小板减少症的血小板生成素（TPO）受体激动剂。

Avoralstat;BCX-4161; BCX-V; BCXV， CAS：918407-35-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.一种潜在的治疗遗传性血管性水肿的血浆激肽释放酶抑制剂。

Avosentan;SPP-301; R-639; RO-67-0565; RO-670565，CAS：290815-26-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗糖尿病性肾病的内皮素受体拮抗剂。

AZD-4547;CAS：1394854-62-6, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗实体肿瘤的纤维母细胞生长因子受体抑制剂。

Azeliragon;TTP-488; PF-04494700，CAS：603148-36-3, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗治疗阿尔茨海默病的糖化终末产物受体抑制剂。

Balaglitazone;DRF-2593; NNC-61-0645; NNC-61-2344; NN-2344; NNC-610645

CAS：199113-98-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗2型糖尿病的过氧化物酶体增殖物活化受体激动剂。

Beclabuvir;BMS-791325，CAS：958002-33-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的用于治疗丙型肝炎的NS5B RNA聚合酶抑制剂。

Benvitimod (苯烯莫德);WB-1001; WBI-1001，CAS：79338-84-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗过敏性皮肤炎与牛皮癣的非甾体抗炎药。

Betrixaban;MK-4448; PRT-021; PRT-054021; MLN-1021， CAS：330942-05-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的用于治疗静脉血栓栓塞(VTE)的凝血因子Xa抑制剂。

Binimetinib;MEK-162; ARRY-162; ARRY-438162，CAS：606143-89-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗NRAS变异性黑色素瘤、卵巢癌、输卵管癌或腹膜癌的MEK抑制剂。

Brincidofovir;CMX-001; HDP-CDV; HDPCDV，CAS：444805-28-1, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗巨细胞病毒感染，天花感染和腺病毒感染的DNA聚合酶抑制剂。

Brivanib Alaninate;BMS-582664 ，CAS：649735-63-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗转移性结直肠癌和肝癌的血管内皮生长因子抑制剂和纤维母细胞生长因子抑制剂。

Buparlisib;BKM-120; NVP-BKM-120; NVPBKM-120, CAS;944396-07-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗乳腺癌的磷脂酰肌醇-3-羟激酶抑制剂。

Cadazolid;ACT-179811，CAS；1025097-10-2, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗艰难梭状芽孢杆菌感染的艰难梭菌蛋白合成抑制剂。

Carboxyamidotriazole (羧胺三唑);RFE-007; NSC-609974; L-651582, CAS:99519-84-3, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗非小细胞肺癌和年龄相关性黄斑变性的钙通道阻滞剂。

Cebranopadol hemicitrate;GRT-6005

CAS: 863513-92-2(Cebranopadol Hemicitrate), 863513-91-1(Cebranopadol), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗神经性疼痛与骨性关节炎疼痛的阿片受体激动剂。

Cilengitide;EMD-121974; EMD-85189; NSC-707544， CAS：188968-51-6, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗胶质母细胞瘤的血管生成/整合素受体拮抗剂。

Cilomilast;SB-207499，CAS：153259-65-5, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗慢性阻塞性肺病的磷酸二酯酶4抑制剂。

Cizolirtine Citrate;E-3710 citrate; E-4018; E-4960 ((R)-isomer); E-4961 ((S)-isomer)

CAS：142155-43-9(Cizolirtine)， 251375-82-3(E-4018), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗疼痛、膀胱过度活动症和尿失禁的降钙素基因相关肽拮抗剂。

Copanlisib Hydrochloride;BAY-84-1236; BAY-841236

CAS：1032568-63-0(Copanlisib)，1402152-13-9(Copanlisib Dihydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗淋巴瘤和实体瘤的磷脂酰肌醇-3-羟激酶抑制剂。

Ampalex;CX-516; BDP-12; SPD-420，CAS：154235-83-3, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗精神分裂症的AMPA受体调制器。

Dacomitinib;PF-00299804; PF-299; PF-299804

CAS;1110813-31-4(Dacomitinib), 1042385-75-0(Dacomitinib Monhydrate), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗非小细胞肺癌的表皮生长因子受体抑制剂。

Dalcetrapib;JTT-705; R-1658; RG-1658; RO-4607381，CAS；211513-37-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗急性冠脉综合征的胆固醇转运蛋白（CETP）抑制剂。

Dapaconazole;BL-123; BL-125, CAS: 1269726-67-1, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗真菌感染的咪唑类药物。

Dapivirine;AIDS-105293; R-147681; TMC-120, CAS: 244767-67-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗艾滋病毒感染的非核苷逆转录酶抑制剂。

Darapladib;SB-480848, CAS: 356057-34-6, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗动脉粥样硬化和急性冠脉综合征的脂蛋白相关磷脂酶2（Lp-PLA2）抑制剂。

Darexaban Maleate;YM-150

CAS: 365462-23-3(Darexaban), 365462-24-4(YM-150), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一个潜在的治疗血栓栓塞的凝血因子Xa抑制剂。

Decernotinib;VTR-831509; VX-509, CAS: 944842-54-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗类风湿性关节炎的Jak3激酶抑制剂。

Deleobuvir Sodium;BI-207127NA

CAS: 1370023-80-5(Deleobuvir Sodium), 863884-77-9(Deleobuvir), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗丙肝病毒感染的NS5B抑制剂。

Diindolylmethane;BR-DIM; DIM, CAS: 1968-05-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗宫颈癌的雄激素受体拮抗剂。

Dimesna;BNP-7787; NSC-716976, CAS:45127-11-5, 16208-51-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗肺癌的的抗氧化剂。

Dinaciclib;MK-7965; NSC-727135; SCH-727965; PS-095760

CAS: 779353-01-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的用于治疗慢性淋巴细胞白血病（CLL）的选择性细胞周期蛋白依赖性激酶抑制剂。

Doravirine;MK-1439; MK-1439A

CAS: 1338225-97-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗艾滋病毒感染的非核苷逆转录酶抑制剂。

Duvelisib;INK-1197; IPI-145; ABBV-954

CAS: 1201438-56-3, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗慢性淋巴细胞白血病，滤泡性淋巴瘤及非霍奇金淋巴瘤的的磷脂酰肌醇3激酶-γ/δ抑制剂。

Emixustat Hydrochloride;ACU-4429; ACU-02; ACU-4429 HCl

CAS: 1141777-14-1(Emixustat), 1141934-97-5(Emixustat Hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗干性年龄相关黄斑变性（AMD）的视网膜色素上皮细胞特异性蛋白酶抑制剂。

Encenicline Hydrochloride;EVP-6124; MT-4666

CAS：550999-75-2(Encenicline)， 550999-74-1(Encenicline Hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗阿尔茨海默症及精神分裂症的烟碱α7激动剂。

Encorafenib;LGX-818; NVP-LGX-818; NVP-LGX-818-NXA

CAS：1269440-17-6, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗BRAF变异型黑色素瘤的Raf激酶抑制剂。

Entinostat (恩替诺特);MS-275; SNDX-275; NSC-706995; MS-27275

CAS：209783-80-2, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗乳腺癌的组蛋白去乙酰酶（HDAC）抑制剂。

Eravacycline;TP-434， CAS：1207283-85-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗复杂尿路感染和复杂腹腔感染的四环素类抗生素。

Esketamine Hydrochloride;JNJ-54135419

CAS：33643-46-8(Esketamine)，33643-47-9(Esketamine Hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗抑郁症的多巴胺再摄取抑制剂。

Evacetrapib;LY-2484595， CAS：1186486-62-3, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种治疗高风险性血管疾病的胆固醇酯转移蛋白(CETP)抑制剂。

Evofosfamide;HAP-302; TH-302，CAS：918633-87-1，, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗软组织肉瘤和胰腺癌的DNA烷化剂。

Evogliptin hydrochloride;DA-1229

CAS：1222102-29-5(Evogliptin)，1246960-27-9(Evogliptin hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗II型糖尿病的DPP-IV抑制剂

Fasiglifam;TAK-875， CAS：1000413-72-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗2型糖尿病的游离脂肪酸受体激动剂。

Fevipiprant;QAW-039， CAS：872365-14-5, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗哮喘，过敏性皮炎和过敏性鼻炎的前列腺素D2受体拮抗剂。

FK-3311; CAS：116686-15-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗风湿性关节炎的前列腺素受体拮抗剂。

Flumatinib Mesylate (甲磺酸氟马替尼);HH-GV-678; HHGV-678

CAS：895519-90-1(Flumatinib)， 895519-91-2(Flumatinib Mesylate), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗慢性髓性白血病（CML）的Bcr-Abl酪氨酸激酶抑制剂。

Fosbretabulin Disodium (康普瑞丁磷酸二钠);CA-4P; CA-4DP; NSC-752293

CAS：222030-63-9(Fosbretabulin )， 168555-66-6(Fosbretabulin Disodium), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗铂类耐药卵巢癌及多形性成胶质细胞瘤的微管蛋白聚合酶抑制剂。

Fostamatinib Disodium Hydrate;NSC-745942; R-788; R-935788

CAS：901119-35-5(Fostamatinib)， 914295-16-2(Fostamatinib Disodium), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗特发性血小板减少性紫癜的脾酪氨酸激酶和Fms样酪氨酸激酶-3抑制剂。

Fostemsavir;BMS-663068，CAS：864953-29-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗艾滋病毒感染的包膜糖蛋白抑制剂。

Fruquintinib (呋喹替尼);HMPL-013, CAS:1194506-26-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的用于治疗结直肠癌和非小细胞肺癌的血管内皮生长因子受体抑制剂。

Galeterone;TOK-001; VN; 124; 124-1, CAS: 851983-85-2, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗前列腺癌的选择性雄激素受体调节剂。

Ganetespib;STA-9090, CAS: 888216-25-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的用于治疗急性髓系白血病的热休克蛋白90（HSP90）抑制剂。

Gilteritinib;ASP-2215， CAS: 1254053-43-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗急性髓系白血病的FLT3/AXL抑制剂。

Eleclazine;GS-6615, CAS: 1443211-72-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗3型长QT综合征的晚钠电流抑制剂。

Guadecitabine Sodium;SGI-110; S-110, CAS: 929901-49-5(Guadecitabine)

929904-85-8(Guadecitabine sodium), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗卵巢癌，肝癌和急性髓系白血病的DNA甲基转移酶抑制剂。

Honokiol;CAS: 35354-74-6, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在治疗牙龈疾病的AKT磷酸化抑制剂与细胞外信号调节激酶（ERK）磷酸化抑制剂。

HT-61;HY-50A， CAS：936622-80-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗葡萄球菌感染的吡咯并喹诺酮类抗生素。

Ibodutant;MEN-15596，CAS：522664-63-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的用于治疗伴有腹泻的肠易激综合征的速激肽NK2拮抗剂。

Idalopirdine;Lu-AE-58054; SGS-518; Lu AE-58054

CAS： 467459-31-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗阿尔茨海默氏病的选择性5羟色胺（5-HT6）受体拮抗剂。

Ivabradine sulfate;CAS：155974-00-8(Ivabradine)，1202000-62-1(Ivabradine sulfate), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗心脏衰竭的HCN [If] 阻滞剂。

K-877;CAS：848259-27-8, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗血脂异常综合征的过氧化物酶体增殖物活化受体-α激动剂。

Laquinimod Sodium;ABR-215062; SAIK-MS; TV-5600

CAS：248281-84-7(Laquinimod)，248282-07-7(Laquinimod Sodium), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗多发性硬化的强效免疫调节剂。

Lascufloxacin; KRP-AM-1977; KRP-AM-1977X。 CAS：848416-07-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗革兰氏阳性细菌感染的药物。

Lasmiditan Hydrochloride;LY-573144; COL-144

CAS：439239-90-4,613677-28-4(Lasmiditan Hydrochloride), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

一种潜在的治疗急性偏头痛的5-羟色胺1F型受体激动剂。

2017 China CPHI: E1M35

EOS Med Chem, Medchem is Big

執大象，天下往，往而無害，安平泰

網址: www.eosmedchem.com

労働時間: Beijing Time 4:00AM~11:00PM

郵箱: info@eosmedchem.com ; eosmedchem@gmail.com

辦公室: 0086-531-69905422-806(直通)

攜帶番號 & WhatsApp & Wechat: +8618653174435

住所: Diaozhen Chemical Industrial Park, Jinan City, China

Skype: willgutian

QQ: 2393923585

Eos Med Chem, Product List--Small molecule inhibitors of Clinical---40026

Small molecule inhibitors of Clinical:

Acalabrutinib (ACP-196);CAS#1420477-60-6

ACP-196 is an orally available inhibitor of Bruton‘s tyrosine kinase (BTK) with potential antineoplastic activity. It inhibits the activity of BTK and prevents the activation of the B-cell antigen, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Alofanib;RPT835;CAS#1612888-66-0

Alofanib, also known as RPT835, is a potent and selective allosteric inhibitor of FGFR2 with potential anticancer activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Altiratinib (DCC-2701);CAS#1345847-93-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Altiratinib (DCC-2701) is a potent inhibitor of c-MET/TIE-2/VEGFR with IC50 values of 2.7, 8.0 and 9.2 nM, respectively, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Amcasertib;CAS#1129403-56-0

Amcasertib is a potent and selective CSCPK inhibitor with potential anticancer activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Apalutamide (ARN-509) ;CAS#: 956104-40-8

Apalutamide, also known as ARN-509 and JNJ-56021927 , is an androgen receptor antagonist with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Belizatinib;TSR011;CAS#1357920-84-3

Belizatinib, also known as TSR-011, is an orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Bexagliflozin;CAS#1118567-05-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Bictegravir;GS 9883;CAS#1611493-60-7, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Brigatinib (AP26113);CAS#1197953-54-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual ALK/EGFR inhibitor. AP26113 binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms。

Capsaicin;CAS#404-86-4, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Cenerimod;ACT-334441;CAS#1262414-04-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Cenerimod is a potent and orally active immunomodulator, exhibited EC50 value of 2.7 nM. Cenerimod is an agonist for the G protein-coupled receptor S1 P1/EDG1 and has a powerful and long-lasting immunomodulating effect which is achieved by reducing the number of circulating and infiltrating T- and B-lymphocytes, without affecting their maturation, memory, or expansion。

Cenobamate;YKP-3089;CAS#913088-80-9, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Cenobamate, also known as YKP-3089, is a novel new antiepileptic drug candidate, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Daprodustat;GSK1278863;CAS#960539-70-2

Daprodustat, also known as GSK1278863, is a novel HIF-prolyl hydroxylase inhibitor. Hypoxia inducible factor (HIF) stabilization by HIF-prolyl hydroxylase (PHD) inhibitors may improve ischemic conditions such as peripheral artery disease (PAD), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Enasidenib;AG-221;CC-90007;CAS#1446502-11-9

Enasidenib, aslo known as AG-221 and CC-90007, is a potent and selective IDH2 inhibitor with potential anticancer activity (IDH2 = Isocitrate dehydrogenase 2), HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Enerisant;CAS#1152747-82-4

Enerisant is a histamine H3 receptor antagonist. In H3 receptor binding assay using (R)-α-methyl[3H]histamine, Enerisant showed IC50 of 4.9 nM. Enerisant may be useful for the treatment of Alzheimer's disease, schizophrenia, etc, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Entrectinib;RXDX-101;NMS-E628;CAS#1108743-60-7

Entrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well as ROS1 and ALK, with high potency and selectivity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Erdafitinib;JNJ-42756493;CAS#1346242-81-6

Erdafitinib, also known as JNJ-42756493, is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Etripamil;MSP-2017;CAS#1593673-23-4

Etripamil is a calcium channel blocker. Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are several medications that disrupt the movement of calcium (Ca2+) through calcium channels, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Evenamide;NW-3509;CAS#1092977-61-1

Evenamide is a sodium and/or calcium channel modulator. Evenamide may be potentia useful in preventing, alleviating and curing a wide range of pathologies, including, but not limited to, neurol., cognitive, psychiatric, inflammatory, urogenital and gastrointestinal diseases, where the above mechanisms have been described as playing a pathol. Role, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Evocalcet;MT-4580;CAS#870964-67-3

Evocalcet is a calcium-sensing receptor agonist. The calcium-sensing receptor (CaSR) is a Class C G-protein coupled receptor which senses extracellular levels of calcium ion, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Ezutromid;BMN195;SMTC-1100;CAS#945531-77-1

Ezutromid,also known as BMN-195 and SMTC-1100, is a first orally bioavailable utrophin's translation modulator, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Fosnetupitant;CAS#1703748-89-3

Fosnetupitant is a neurokinin receptor antagonist. Neurokinin 1 (NK1) receptor antagonists (RAs) are a class of drug used to treat nausea and vomiting associated with chemotherapy. Aprepitant, casopitant, and fosaprepitant are NK1 drugs, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Merestinib (LY2801653);CAS#1206799-15-6

Merestinib, also known as LY2801653, is a n orally available, small molecule inhibitor of the proto-oncogene c-Met (mesenchymal-epithelial transition, also known as hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Nastorazepide (Z-360);CAS#209219-38-5

Nastorazepide, also known as Z-360, is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Neladenoson bialanate;CAS#1239309-58-0, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Netarsudil;AR-11324;CAS#1254032-66-0

Netarsudil, also known as AR-11324, is a Rho-associated protein kinase inhibitor. Netarsudil is potential useful for treating glaucoma and/or reducing intraocular pressure, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Pemafibrate;K-877;CAS#848259-27-8

Pemafibrate, also known as K-877 and (R)-K 13675, is a PPAR alpha agonist. (R)-K-13675 decreases the secretion of inflammatory markers without affecting cell proliferation or tube formation, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Sacubitrilat (LBQ-657);CAS#149709-44-4

Sacubitrilat, also known as LBQ-657, is endopeptidase inhibitor. Sacubitril is a prodrug that is activated to LBQ657 by de-ethylation via esterases, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Selonsertib (GS-4997) CAS#1448428-04-3(free base); 1448428-05-4(HCl salt)

Selonsertib, also known as GS-4997, is an orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with potential anti-inflammatory, antineoplastic and anti-fibrotic activities, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Sparsentan (RE-021);CAS#254740-64-2

Sparsentan, also known as RE-021, BMS346567, PS433540 and DARA-a, is a Dual angiotensin II and endothelin A receptor antagonist, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Tucatinib(ARRY380);CAS#937263-43-9

Tucatinib, also known as Irbinitinib, ARRY-380 and ONT-380, is a n orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Vesatolimod;GS-9620;CAS#1228585-88-3

Vesatolimod, also known as GS-9620, is a potent and oral agonist of Toll-like receptor-7 developed for finite treatment of chronic hepatitis B viral (HBV) infection, with the goal of inducing a liver-targeted antiviral effect without inducing the adverse effects associated with current systemic interferon-α (IFN-α) therapies, HPLC 99%, NMR, LCMS is ok, stock more than 10g.

Vistusertib;AZD-2014;CAS#1009298-59-2

Vistusertib, also known as AZD2014, is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity, HPLC 99%, NMR, LCMS is ok, stock more than 10g.